can tirzepatide cause heart problems UC Irvine researchers project cardiac benefits from weight-loss medication 📌 Most viewed this week

At the same time, both therapies highlight how much obesity treatment has evolved

Should GLP-1 patches complete clinical development and receive regulatory approval in future, they would undergo health technology assessment by NICE to determine cost-effectiveness and appropriate positioning within NHS treatment pathways

Valencio ACJ, Antunes AB, Fonseca L, et al

In a cohort study recently published in JAMA Internal Medicine , researchers set out to provide a head-to-head comparison of these medications in a real-world clinical setting, focusing on weight loss outcomes and gastrointestinal adverse events (AEs)

Start your intake Brand name versus active ingredient The active ingredient, also called the generic or nonproprietary name, identifies the molecule itself what is chemically present in the pen or tablet

How the Clinics Protocol Works The consultation begins with an unhurried read of your goals, medical history, and metabolic context